Medicare could cut its prescription drug spending by several millions of dollars annually if HHS Secretary Kathleen Sebelius exercised her existing authority, according to the agency's inspector general. Report
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Comments